ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

December 3, 2010

Mihich Recommendation for Antigen Development In BRMP Summarized

December 14, 1979

NCI Smoking Nears Goals With “New Generation”

January 9, 1976

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014